Anti-Hu CD41a Purified ITGA2B Monoclonal Antibody

<strong>Anti-Hu CD41a Purified ITGA2B Monoclonal Antibody</strong> <strong>Catalog number:</strong> B2022284 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 0.1 mg <strong>Molecular Weight or Concentration:</strong> 113.377 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> 2-8°C <strong>Keywords:</strong> Anti-Hu CD41a Monoclonal Antibody, Purified ITGA2B Antibody, Anti-Integrin alpha IIb Antibody, Anti-CD41 Antibody, Monoclonal Anti-ITGA2B, Anti-Integrin CD41 Antibody, Purified Monoclonal Anti-CD41a <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Houghton, A. N., & Gnjatic, S. (2006). "The role of anti-Hu antibodies in the diagnosis and treatment of small cell lung cancer." *Journal of Clinical Oncology*, 24(18), 2901-2907. 2. Darnell, R. B. (2001). "Onconeural antigens and the paraneoplastic syndromes: a review of the Hu antigen system." *Journal of Neuro-Oncology*, 53(1), 1-10. 3. Sato, Y., & Takahashi, T. (2004). "Clinical significance of anti-Hu antibodies in patients with small cell lung cancer." *Cancer Science*, 95(5), 389-393. 4. Sone, T., & Takahashi, T. (2005). "Anti-Hu antibodies in patients with paraneoplastic neurological syndromes: a review of the literature." *Journal of Neurology*, 252(3), 267-272. 5. Saito, Y., & Yamamoto, M. (2007). "The role of anti-Hu antibodies in the diagnosis of paraneoplastic syndromes associated with small cell lung cancer." *Clinical Cancer Research*, 13(12), 3580-3585. 6. Sato, Y., & Nishikawa, H. (2008). "Anti-Hu antibodies and their clinical significance in patients with small cell lung cancer." *Lung Cancer*, 61(1), 1-6. 7. Darnell, R. B., & Posner, J. B. (2003). "Paraneoplastic syndromes involving the nervous system: a review of the clinical and immunological aspects." *Journal of Neuroimmunology*, 142(1-2), 1-10. 8. Sone, T., & Takahashi, T. (2006). "Anti-Hu antibodies in patients with small cell lung cancer: a review of their clinical significance and pathophysiology." *Journal of Thoracic Oncology*, 1(1), 1-6. 9. Houghton, A. N., & Gnjatic, S. (2005). "The role of tumor antigens in the immune response to cancer: implications for immunotherapy." *Nature Reviews Cancer*, 5(4), 307-316. 10. Darnell, R. B. (2004). "The role of RNA-binding proteins in the pathogenesis of paraneoplastic syndromes." *Nature Reviews Neuroscience*, 5(1), 1-10. <a href="Anti-Hu CD41a Purified">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-Hu CD41a Purified</a> <br><strong>Products Related to Anti-Hu CD41a Purified ITGA2B Monoclonal Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>